UK report calls for creation of a single medical research regulator
This article was originally published in Scrip
Regulatory processes for medical research in the UK should be streamlined and brought under the ambit of a new, single, independent Health Research Agency (HRA), the Academy of Medical Sciences has recommended in a report to the government.
You may also be interested in...
As companies undergo pharmacovigilance inspections from a growing multitude of regulatory authorities from around the globe, a senior pharmaceutical industry executive discusses how her company has been handling this complex and challenging task.
While inspection interviews can be stressful for drug firms, a Dutch pharmacovigilance inspector reassures companies that any responses made during the process cannot undo any good work they have already done. And they can also correct any wrong answers later on.
The Saudi Food & Drug Authority looks at the number of individual case safety reports (ICSRs) submitted by a company, among other risk-based factors, when drawing up its list for routine pharmacovigilance inspections.